ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,782 | +27.3% | 74,400 | 0.0% | 0.06% | +1.6% |
| Q1 2023 | $1,400 | -99.9% | 74,400 | 0.0% | 0.06% | +3.4% |
| Q4 2022 | $1,184,448 | -2.7% | 74,400 | 0.0% | 0.06% | -14.5% |
| Q3 2022 | $1,217,000 | +16.1% | 74,400 | 0.0% | 0.07% | -9.2% |
| Q2 2022 | $1,048,000 | -41.8% | 74,400 | 0.0% | 0.08% | -2.6% |
| Q1 2022 | $1,802,000 | +3.8% | 74,400 | 0.0% | 0.08% | +23.8% |
| Q4 2021 | $1,736,000 | +40.5% | 74,400 | 0.0% | 0.06% | +57.5% |
| Q3 2021 | $1,236,000 | -31.9% | 74,400 | 0.0% | 0.04% | -11.1% |
| Q2 2021 | $1,815,000 | – | 74,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |